Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke

NCT00069069 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00069069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00069069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 1
Overall status
Withdrawn
Start date
October 1, 2003
Completion date
May 9, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic attack, transient, transient